scispace - formally typeset
J

Jose C. Florez

Researcher at Harvard University

Publications -  414
Citations -  58686

Jose C. Florez is an academic researcher from Harvard University. The author has contributed to research in topics: Type 2 diabetes & Diabetes mellitus. The author has an hindex of 87, co-authored 357 publications receiving 50750 citations. Previous affiliations of Jose C. Florez include George Washington University & University of California, Davis.

Papers
More filters
Journal ArticleDOI

Six-Year Diabetes Incidence After Genetic Risk Testing and Counseling: A Randomized Clinical Trial.

TL;DR: It is demonstrated in the Genetic Counseling/Lifestyle Change (GC/LC) Study that learning one’s genetic risk did not impact short-term weight loss or behavior change motivation among participants in a diabetes prevention program.
Journal ArticleDOI

Found in Translation: A Type 1 Diabetes Genetic Risk Score Applied to Clinical Diagnosis

TL;DR: Meta-analyses of genome-wide association studies (GWAS) and ongoing comprehensive sequencing experiments are yielding a plethora of genetic associations from an agnostic vantage point, which can open unsuspected windows into the pathophysiology of metabolic phenotypes, including type 1 and type 2 diabetes.
Posted ContentDOI

Protein-coding variants implicate novel genes related to lipid homeostasis contributing to body fat distribution

Anne E. Justice, +278 more
- 30 Jun 2018 - 
TL;DR: By examining variants often poorly tagged or entirely missed by genome-wide association studies, novel genes in fat distribution are implicate, stressing the importance of interrogating low-frequency and protein-coding variants.
Journal ArticleDOI

High-throughput genetic clustering of type 2 diabetes loci reveals heterogeneous mechanistic pathways of metabolic disease

TL;DR: In this article , a high-throughput pipeline was developed to enable clustering of type 2 diabetes loci based on variant-trait associations and applied Bayesian non-negative matrix factorisation (bNMF) to identify genetic components of Type 2 diabetes.
Journal ArticleDOI

The Effect of Interventions to Prevent Type 2 Diabetes on the Development of Diabetic Retinopathy: The DPP/DPPOS Experience

Neil H. White, +613 more
- 25 May 2022 - 
TL;DR: Interventions that delay or prevent the onset of type 2 diabetes in overweight/obese subjects with dysglycemia who are at risk for diabetes do not reduce the development of diabetic retinopathy for up to 20 years.